About
Basic Data Updated:
24 days agoPandorum Technologies Private Limited was founded with a vision to revolutionize the medical industry. The company specializes in designing and producing three-dimensional functional human tissues, which are used for medical research and therapeutics. Our team of experts is dedicated to pushing the boundaries of science and technology through innovative multidisciplinary research. The company was incorporated with the purpose of providing customized solution services, generating intellectual property, and developing cutting-edge technology. Our focus lies in the fields of advanced material, biotechnology, and nanotechnology. We strive to stay at the forefront of these industries, constantly seeking new and improved ways to enhance human health and well-being. At Pandorum Technologies, we are committed to making a positive impact on society through our work. Our passion for innovation and dedication to excellence drives us to continuously push the boundaries of what is possible. We believe that our efforts will contribute to the advancement of medical research and ultimately improve the lives of people around the world. With a team of highly skilled and experienced professionals, we are confident in our ability to deliver top-quality products and services. Our goal is to be a leader in the field of regenerative medicine and to make a significant difference in the lives of patients and healthcare professionals alike.
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
CIN/LLPIN/FCRN | U72200KA2011PTC058650 |
Company No. | 058650 |
Company Classification | Private Limited Indian Non-Government Company |
Incorporation Date | 16 May 2011 |
Date of AGM | 30 Dec 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Unlisted |
ROC Code | Roc Bangalore |
Financials of Pandorum Technologies Private Limited
Pandorum Technologies Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.73% decrease. The company also saw a substantial improvement in profitability, with a 17.52% increase in profit. The company's net worth Soared by an impressive increase of 595.3%.
Corporate Structure
Unlock access to Pandorum Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Pandorum Technologies Private Limited
Unlock and access historical data on people associated with Pandorum Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(6)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pandorum Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pandorum Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Recent activity within the organization
Annual General Meeting
Pandorum Technologies Private Limited last Annual general meeting of members was held on 30 Dec 2023 as per latest MCA records.
30 Dec 2023Balance Sheet
Pandorum Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
31 Mar 2023Director Appointment
Sudipta Gautam was appointed as a Nominee Director was appointed as a Nominee Director on 18 Dec 2019 & has been associated with this company since 4 years 5 months .
18 Dec 2019Director Appointment
Sailesh Tulshan was appointed as a Director was appointed as a Director on 10 Aug 2018 & has been associated with this company since 5 years 9 months .
10 Aug 2018Director Appointment
Manish Kumar Belmannu was appointed as a Nominee Director was appointed as a Nominee Director on 18 Jul 2018 & has been associated with this company since 5 years 10 months .
18 Jul 2018
Recent News, Updates & Announcement
- Pandorum Technologies secures USD 11 million investment to advance its regenerative therapy for corneal.
PRNewswireBengaluru Karnataka India March 15 Pandorum Technologies a leading biotechnology company announced today the successful closure of a preSeries B funding round securing USD 11 million INR 88 crore in investment The funding was sourced from Mr Ashish Kacholia Everest Finance Investment Acebright Pharma and Ms Bandana Kankanis syndicate along with existing investors Mr Sunil Kant Munjal and the Indian Angel NetworkFounded by Arun Chandru Dr Tuhin Bhowmick the startup company focuses on Tissue Engineering and Regenerative Medicine With the current round of funding Pandorum aims to progress towards the FirstinHuman study of its Flagship product Kuragenx the Liquid Cornea to treat corneal blindness The funding will also allow the company to advance its tunable technology platform that has demonstrated regenerative potential beyond cornea such as for liver lung and neuronal tissuesWe are thrilled to have the support of the notable investors including Mr Ashish Kacholia as we continue to innovate and develop therapeutics to restore healthy tissue functions in order to help the patients suffering from unmet clinical needs Our flagship product Kuragenx combines proprietary biomaterials with regenerative nanotherapy guiding the formation of a functional corneal tissue to restore vision This is a FirstinClass approach that can truly blur the line between treatment and cure said Dr Tuhin Bhowmick CoFounder CEO of Pandorum TechnologiesMr Ashish Kacholia said This startup is working on cure for corneal blindness Though the journey to commercialization is long amazing payoffs possible for all mankind Indian science and scientific community making amazing stridesTheres a paradigm shift happening in the Indian biotech and lifescience sector with deeptech companies like Pandorum pushing boundaries and creating global innovations My best wishes to the team for what they have set out to accomplish said Ms Bandana Kankani from Nexxtmile who invested and also advised on this funding roundIt is inspiring to see a company originating from India started by two young founders poised to change the landscape of cornea transplant and blindness in the world We are glad to support the team as they navigate the path towards commercializing their cornea regeneration platform Kuragenx said Mr Ashish Sheth Partner at Orbit Financial Capital OFC OFC acted as buyside advisor to Acebright PharmaCorneal opacity is one of the major causes of blindness worldwide with millions waiting for donor tissues against significant odds Pandorums Kuragenx promotes scarless regeneration of cornea tissue to restore vision as demonstrated in extensive preclinical studies In 2023 Kuragenx was awarded the Orphan Drug Designation by the USFDA for the treatment of Neurotrophic Keratitis a form of ulcerative corneal blindness that is currently untreatable or extremely difficult to treat Pandorum is currently engaged in clinical manufacturing process and IND enabling studies of Kuragenx with the aim towards the first patient dosing in 2025 after obtaining due regulatory approvalsGiving back vision with something made in the lab without depending on donor corneas is truly transformative Kudos to our team at Pandorum Could not have been possible without the support of our investors partners and the Government enabled RD ecosystem Indeed its a multibillion dollar global opportunity more so this will positively impact millions of lives said Arun Chandru CoFounder Director of the companyPandorum has its RD labs in Bangalore India and in the Bay Area San Francisco USA and works with prominent global partners The company has received competitive grants from the Department of Biotechnology Government of India and has previously raised funds from marquee investors and VCs including Sunil Kant Munjal Binny Bansal T K Kurien Sachin Bansal 021 Capital Indian Angel Network IAN Fund Karnataka Venture Fund KITVEN Kotak Investment Advisors and 500 StartupsFor more information visit wwwpandorumcomLogo httpsmmaprnewswirecommedia2362884Pandorum_LogojpgADVERTORIAL DISCLAIMER The above press release has been provided by PRNewswirewill not be responsible in any way for the content of the sameDisclaimer This post has been autopublished from an agency feed without any modifications to the text and has not been reviewed by an editor.
Lokmat News 15 Mar 2024
- Pandorum Technologies launches Centre to offer regenerative therapy for corneal blindness.
BioSpectrum India 14 Jun 2023
- Indian Biotech Startups Defy Odds Bugworks and Pandorum Win ET Startup Awards for Global Impact and Revolutionary Breakthroughs.
Indias biotech startups making global impact despite challenges Bugworks beats superbugs with new antibiotics Pandorum 3Dprints human tissues for medical research Both win ET Startup Awards Bugworks CEO humbled says last antibiotic breakthrough in 1984 Pandorum aims to make personalized organs Both funded by BIRAC Biocons Kiran MazumdarShaw impressed Tough for biotech to scale up but grateful for Indian ecosystem.
Economic Times 24 Jul 2017
Frequently asked questions
What is the Incorporation or founding date of Pandorum Technologies Private Limited?